메뉴 건너뛰기




Volumn 30, Issue 19, 2012, Pages 2408-2417

Platinum-induced ototoxicity in children: A consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMIFOSTINE; CISPLATIN; DEXAMETHASONE; DNA; EBSELEN; METHIONINE; PLATINUM DERIVATIVE; RINGER SOLUTION; SODIUM THIOSULFATE;

EID: 84863993868     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.39.1110     Document Type: Review
Times cited : (300)

References (111)
  • 1
    • 84889894703 scopus 로고    scopus 로고
    • May 10, update
    • National Cancer Institute: Cancer Drug Information: Cisplatin, May 10, 2011 update. http://www.cancer.gov/cancertopics/druginfo/cisplatin
    • (2011) Cancer Drug Information: Cisplatin
  • 2
    • 33644848462 scopus 로고    scopus 로고
    • Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development
    • DOI 10.1200/JCO.2004.00.5355
    • Knight KR, Kraemer DF, Neuwelt EA: Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol 23:8588-8596, 2005 (Pubitemid 46211500)
    • (2005) Journal of Clinical Oncology , vol.23 , Issue.34 , pp. 8588-8596
    • Knight, K.R.G.1    Kraemer, D.F.2    Neuwelt, E.A.3
  • 3
    • 34247110863 scopus 로고    scopus 로고
    • Early changes in auditory function as a result of platinum chemotherapy: Use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions
    • DOI 10.1200/JCO.2006.07.9723
    • Knight KR, Kraemer DF, Winter C, et al: Early changes in auditory function as a result of platinum chemotherapy: Use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol 25:1190-1195, 2007 (Pubitemid 46640564)
    • (2007) Journal of Clinical Oncology , vol.25 , Issue.10 , pp. 1190-1195
    • Knight, K.R.1    Kraemer, D.P.2    Winter, C.3    Neuwelt, E.A.4
  • 6
    • 0023686138 scopus 로고
    • Ototoxicity of high-dose cis-platinum in children
    • Brock P, Pritchard J, Bellman S, et al: Ototoxicity of high-dose cis-platinum in children. Med Pediatr Oncol 16:368-369, 1988
    • (1988) Med Pediatr Oncol , vol.16 , pp. 368-369
    • Brock, P.1    Pritchard, J.2    Bellman, S.3
  • 7
    • 0025864140 scopus 로고
    • Cisplatin ototoxicity in children: A practical grading system
    • Brock PR, Bellman SC, Yeomans EC, et al: Cisplatin ototoxicity in children: A practical grading system. Med Pediatr Oncol 19:295-300, 1991
    • (1991) Med Pediatr Oncol , vol.19 , pp. 295-300
    • Brock, P.R.1    Bellman, S.C.2    Yeomans, E.C.3
  • 8
    • 0026683581 scopus 로고
    • Cisplatin therapy in infants: Short and long-term morbidity
    • Brock PR, Yeomans EC, Bellman SC, et al: Cisplatin therapy in infants: Short and long-term morbidity. Br J Cancer Suppl 18:S36-S40, 1992
    • (1992) Br J Cancer Suppl , vol.18
    • Brock, P.R.1    Yeomans, E.C.2    Bellman, S.C.3
  • 9
    • 0024525184 scopus 로고
    • Enhanced cis-platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation
    • Walker DA, Pillow J, Waters KD, et al: Enhanced cis-platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation. Med Pediatr Oncol 17:48-52, 1989
    • (1989) Med Pediatr Oncol , vol.17 , pp. 48-52
    • Walker, D.A.1    Pillow, J.2    Waters, K.D.3
  • 10
    • 52449096175 scopus 로고    scopus 로고
    • Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
    • author reply 1334-1335
    • Bhutani M, Pathak AK: Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 100:1334, 2008; author reply 1334-1335
    • (2008) J Natl Cancer Inst , vol.100 , pp. 1334
    • Bhutani, M.1    Pathak, A.K.2
  • 12
    • 59049105617 scopus 로고    scopus 로고
    • Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
    • author reply 125-126
    • Block K, Koch A, Mead M, et al: Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 101:124-125, 2009; author reply 125-126
    • (2009) J Natl Cancer Inst , vol.101 , pp. 124-125
    • Block, K.1    Koch, A.2    Mead, M.3
  • 13
    • 2142788844 scopus 로고    scopus 로고
    • Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model
    • DOI 10.1016/j.heares.2004.02.007, PII S0378595504000814
    • Thomas Dickey D, Muldoon LL, Kraemer DF, et al: Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear Res 193: 25-30, 2004 (Pubitemid 38813422)
    • (2004) Hearing Research , vol.193 , Issue.1-2 , pp. 25-30
    • Dickey, D.T.1    Muldoon, L.L.2    Kraemer, D.F.3    Neuwelt, E.A.4
  • 14
    • 23944447422 scopus 로고    scopus 로고
    • Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels
    • DOI 10.1124/jpet.105.087601
    • Dickey DT, Wu YJ, Muldoon LL, et al: Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J Pharmacol Exp Ther 314: 1052-1058, 2005 (Pubitemid 41205968)
    • (2005) Journal of Pharmacology and Experimental Therapeutics , vol.314 , Issue.3 , pp. 1052-1058
    • Dickey, D.T.1    Wu, Y.J.2    Muldoon, L.L.3    Neuwelt, E.A.4
  • 15
    • 0025946498 scopus 로고
    • Dose-dependent inner ear changes after i.v. administration of cisplatin
    • Laurell G, Bagger-Sjöbäck D: Dose-dependent inner ear changes after i.v. administration of cisplatin. J Otolaryngol 20:158-167, 1991
    • (1991) J Otolaryngol , vol.20 , pp. 158-167
    • Laurell, G.1    Bagger-Sjöbäck, D.2
  • 16
    • 0030848637 scopus 로고    scopus 로고
    • Quantitative relationship of carboplatin dose to magnitude of inner and outer hair cell loss and the reduction in distortion product otoacoustic emission amplitude in chinchillas
    • DOI 10.1016/S0378-5955(97)00123-8, PII S0378595597001238
    • Hofstetter P, Ding D, Powers N, et al: Quantitative relationship of carboplatin dose to magnitude of inner and outer hair cell loss and the reduction in distortion product otoacoustic emission amplitude in chinchillas. Hear Res 112:199-215, 1997 (Pubitemid 27435996)
    • (1997) Hearing Research , vol.112 , Issue.1-2 , pp. 199-215
    • Hofstetter, P.1    Ding, D.2    Powers, N.3    Salvi, R.J.4
  • 18
    • 0021930924 scopus 로고
    • Ototoxicity of low- and moderate-dose cisplatin
    • DOI 10.1002/1097-0142(19851015)56:8<1934::AID-CNCR2820560807>3.0. CO;2-F
    • Schaefer SD, Post JD, Close LG, et al: Ototoxicity of low- and moderate-dose cisplatin. Cancer 56:1934-1939, 1985 (Pubitemid 15240862)
    • (1985) Cancer , vol.56 , Issue.8 , pp. 1934-1939
    • Schaefer, S.D.1    Post, J.D.2    Close, L.G.3    Wright, C.G.4
  • 19
    • 0345256652 scopus 로고    scopus 로고
    • Cisplatin: Mode of cytotoxic action and molecular basis of resistance
    • DOI 10.1038/sj.onc.1206933, Drug Resistance
    • Siddik ZH: Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265-7279, 2003 (Pubitemid 37487159)
    • (2003) Oncogene , vol.22 , Issue.47 REV. ISS. 6 , pp. 7265-7279
    • Siddik, Z.H.1
  • 20
    • 70149105274 scopus 로고    scopus 로고
    • Using acetaminophen's toxicity mechanism to enhance cisplatin efficacy in hepatocarcinoma and hepatoblastoma cell lines
    • Neuwelt AJ, Wu YJ, Knap N, et al: Using acetaminophen's toxicity mechanism to enhance cisplatin efficacy in hepatocarcinoma and hepatoblastoma cell lines. Neoplasia 11:1003-1011, 2009
    • (2009) Neoplasia , vol.11 , pp. 1003-1011
    • Neuwelt, A.J.1    Wu, Y.J.2    Knap, N.3
  • 22
    • 34547098814 scopus 로고    scopus 로고
    • Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation
    • DOI 10.1007/s10495-007-0082-8
    • Bragado P, Armesilla A, Silva A, et al: Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis 12:1733-1742, 2007 (Pubitemid 47106882)
    • (2007) Apoptosis , vol.12 , Issue.9 , pp. 1733-1742
    • Bragado, P.1    Armesilla, A.2    Silva, A.3    Porras, A.4
  • 23
    • 36448938351 scopus 로고    scopus 로고
    • The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear
    • García-Berrocal JR, Nevado J, Ramírez-Camach R, et al: The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear. Br J Pharmacol 152:1012-1020, 2007
    • (2007) Br J Pharmacol , vol.152 , pp. 1012-1020
    • García-Berrocal, J.R.1    Nevado, J.2    Ramírez-Camach, R.3
  • 25
    • 0036812470 scopus 로고    scopus 로고
    • Caspase activation in hair cells of the mouse utricle exposed to neomycin
    • Cunningham LL, Cheng AG, Rubel EW: Caspase activation in hair cells of the mouse utricle exposed to neomycin. J Neurosci 22:8532-8540, 2002 (Pubitemid 35387593)
    • (2002) Journal of Neuroscience , vol.22 , Issue.19 , pp. 8532-8540
    • Cunningham, L.L.1    Cheng, A.G.2    Rubel, E.W.3
  • 26
    • 0037083450 scopus 로고    scopus 로고
    • Inhibition of caspases prevents ototoxic and ongoing hair cell death
    • Matsui JI, Ogilvie JM, Warchol ME: Inhibition of caspases prevents ototoxic and ongoing hair cell death. J Neurosci 22:1218-1227, 2002 (Pubitemid 34163723)
    • (2002) Journal of Neuroscience , vol.22 , Issue.4 , pp. 1218-1227
    • Matsui, J.I.1    Ogilvie, J.M.2    Warchol, M.E.3
  • 29
    • 0035397409 scopus 로고    scopus 로고
    • Cisplatin ototoxicity: Involvement of iron and enhanced formation of superoxide anion radicals
    • DOI 10.1006/taap.2001.9171
    • Dehne N, Lautermann J, Petrat F, et al: Cisplatin ototoxicity: Involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 174:27-34, 2001 (Pubitemid 32635003)
    • (2001) Toxicology and Applied Pharmacology , vol.174 , Issue.1 , pp. 27-34
    • Dehne, N.1    Lautermann, J.2    Petrat, F.3    Rauen, U.4    De Groot, H.5
  • 31
    • 33947212468 scopus 로고    scopus 로고
    • Mechanisms of cisplatin-induced ototoxicity and prevention
    • DOI 10.1016/j.heares.2006.09.015, PII S0378595506002723, Pharmacological Strategies for Prevention and Treatment of Hearing Loss and Tinnitus
    • Rybak LP, Whitworth CA, Mukherjea D, et al: Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 226:157-167, 2007 (Pubitemid 46428033)
    • (2007) Hearing Research , vol.226 , Issue.1-2 , pp. 157-167
    • Rybak, L.P.1    Whitworth, C.A.2    Mukherjea, D.3    Ramkumar, V.4
  • 33
    • 0042967906 scopus 로고    scopus 로고
    • Cisplatin ototoxicity in the guinea pig: Vestibular and cochlear damage
    • DOI 10.1016/S0378-5955(03)00142-4
    • Sergi B, Ferraresi A, Troiani D, et al: Cisplatin ototoxicity in the guinea pig: Vestibular and cochlear damage. Hear Res 182:56-64, 2003 (Pubitemid 37013284)
    • (2003) Hearing Research , vol.182 , Issue.1-2 , pp. 56-64
    • Sergi, B.1    Ferraresi, A.2    Troiani, D.3    Paludetti, G.4    Fetoni, A.R.5
  • 34
    • 34147137757 scopus 로고    scopus 로고
    • Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig
    • DOI 10.1159/000099020
    • Laurell G, Ekborn A, Viberg A, et al: Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig. Audiol Neurootol 12:170-178, 2007 (Pubitemid 46558925)
    • (2007) Audiology and Neurotology , vol.12 , Issue.3 , pp. 170-178
    • Laurell, G.1    Ekborn, A.2    Viberg, A.3    Canlon, B.4
  • 35
    • 77955771808 scopus 로고    scopus 로고
    • Competitive antagonism of fluorescent gentamicin uptake in the cochlea
    • Wang Q, Kachelmeier A, Steyger PS: Competitive antagonism of fluorescent gentamicin uptake in the cochlea. Hearing Res 268:250-259, 2010
    • (2010) Hearing Res , vol.268 , pp. 250-259
    • Wang, Q.1    Kachelmeier, A.2    Steyger, P.S.3
  • 36
    • 0019484069 scopus 로고
    • Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II)
    • DOI 10.1007/BF00434394
    • Gormley PE, Gangji D, Wood JH, et al: Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II). Cancer Chemother Pharmacol 5:257-260, 1981 (Pubitemid 11127420)
    • (1981) Cancer Chemotherapy and Pharmacology , vol.5 , Issue.4 , pp. 257-260
    • Gormley, P.E.1    Gangji, D.2    Wood, J.H.3    Poplack, D.G.4
  • 37
    • 14644394281 scopus 로고    scopus 로고
    • Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates
    • Jacobs SS, Fox E, Dennie C, et al: Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates. Clin Cancer Res 11:1669-1674, 2005
    • (2005) Clin Cancer Res , vol.11 , pp. 1669-1674
    • Jacobs, S.S.1    Fox, E.2    Dennie, C.3
  • 38
    • 18044362704 scopus 로고    scopus 로고
    • Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs
    • van Ruijven MW, de Groot JC, Hendriksen F, et al: Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs. Hear Res 203:112-121, 2005
    • (2005) Hear Res , vol.203 , pp. 112-121
    • Van Ruijven, M.W.1    De Groot, J.C.2    Hendriksen, F.3
  • 39
    • 33745278586 scopus 로고    scopus 로고
    • High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity
    • Thomas JP, Lautermann J, Liedert B, et al: High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity. Mol Pharmacol 70:23-29, 2006
    • (2006) Mol Pharmacol , vol.70 , pp. 23-29
    • Thomas, J.P.1    Lautermann, J.2    Liedert, B.3
  • 40
    • 44849099528 scopus 로고    scopus 로고
    • Blood-neural barrier: Its diversity and coordinated cell-to-cell communication
    • Choi YK, Kim KW: Blood-neural barrier: Its diversity and coordinated cell-to-cell communication. BMB Rep 41:345-352, 2008
    • (2008) BMB Rep , vol.41 , pp. 345-352
    • Choi, Y.K.1    Kim, K.W.2
  • 42
    • 70649113052 scopus 로고    scopus 로고
    • Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
    • Ross CJ, Katzov-Eckert H, Dubé MP, et al: Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nat Genet 41:1345-1349, 2009
    • (2009) Nat Genet , vol.41 , pp. 1345-1349
    • Ross, C.J.1    Katzov-Eckert, H.2    Dubé, M.P.3
  • 43
    • 33646246978 scopus 로고    scopus 로고
    • Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer
    • Shord SS, Thompson DM, Krempl GA, et al: Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer. Anticancer Drugs 17:207-215, 2006
    • (2006) Anticancer Drugs , vol.17 , pp. 207-215
    • Shord, S.S.1    Thompson, D.M.2    Krempl, G.A.3
  • 44
    • 0033960541 scopus 로고    scopus 로고
    • Cisplatin-induced hearing loss: Influence of the mode of drug administration in the guinea pig
    • DOI 10.1016/S0378-5955(99)00190-2, PII S0378595599001902
    • Ekborn A, Laurell G, Andersson A, et al: Cisplatin-induced hearing loss: Influence of the mode of drug administration in the guinea pig. Hear Res 140:38-44, 2000 (Pubitemid 30079633)
    • (2000) Hearing Research , vol.140 , Issue.1-2 , pp. 38-44
    • Ekborn, A.1    Laurell, G.2    Andersson, A.3    Wallin, I.4    Eksborg, S.5    Ehrsson, H.6
  • 45
    • 0025844777 scopus 로고
    • Partial reversibility of cisplatin nephrotoxicity in children
    • Brock PR, Koliouskas DE, Barratt TM, et al: Partial reversibility of cisplatin nephrotoxicity in children. J Pediatr 118:531-534, 1991
    • (1991) J Pediatr , vol.118 , pp. 531-534
    • Brock, P.R.1    Koliouskas, D.E.2    Barratt, T.M.3
  • 46
    • 38349168706 scopus 로고    scopus 로고
    • Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
    • Riedemann L, Lanvers C, Deuster D, et al: Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Pharmacogenomics J 8:23-28, 2008
    • (2008) Pharmacogenomics J , vol.8 , pp. 23-28
    • Riedemann, L.1    Lanvers, C.2    Deuster, D.3
  • 47
    • 0033790607 scopus 로고    scopus 로고
    • Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
    • Peters U, Preisler-Adams S, Hebeisen A, et al: Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Drugs 11:639-643, 2000
    • (2000) Anticancer Drugs , vol.11 , pp. 639-643
    • Peters, U.1    Preisler-Adams, S.2    Hebeisen, A.3
  • 48
    • 40949130371 scopus 로고    scopus 로고
    • Platinum resistance: The role of DNA repair pathways
    • DOI 10.1158/1078-0432.CCR-07-2238
    • Martin LP, Hamilton TC, Schilder RJ: Platinum resistance: The role of DNA repair pathways. Clin Cancer Res 14:1291-1295, 2008 (Pubitemid 351413906)
    • (2008) Clinical Cancer Research , vol.14 , Issue.5 , pp. 1291-1295
    • Martin, L.P.1    Hamilton, T.C.2    Schilder, R.J.3
  • 49
    • 4143051317 scopus 로고    scopus 로고
    • Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
    • DOI 10.1158/1078-0432.CCR-04-0247
    • Zhou W, Gurubhagavatula S, Liu G, et al: Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced nonsmall cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 10: 4939-4943, 2004 (Pubitemid 39099767)
    • (2004) Clinical Cancer Research , vol.10 , Issue.15 , pp. 4939-4943
    • Zhou, W.1    Gurubhagavatula, S.2    Liu, G.3    Park, S.4    Neuberg, D.S.5    Wain, J.C.6    Lynch, T.J.7    Su, L.8    Christiani, D.C.9
  • 54
    • 70349678400 scopus 로고    scopus 로고
    • Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients
    • Caronia D, Patiño-García A, Milne RL, et al: Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. Pharmacogenomics J 9:347-353, 2009
    • (2009) Pharmacogenomics J , vol.9 , pp. 347-353
    • Caronia, D.1    Patiño-García, A.2    Milne, R.L.3
  • 55
    • 33947590154 scopus 로고    scopus 로고
    • Cisplatin-induced long-term hearing impairment is associated with specific glutathione S-transferase genotypes in testicular cancer survivors
    • DOI 10.1200/JCO.2006.08.9599
    • Oldenburg J, Kraggerud SM, Cvancarova M, et al: Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors. J Clin Oncol 25:708-714, 2007 (Pubitemid 350002927)
    • (2007) Journal of Clinical Oncology , vol.25 , Issue.6 , pp. 708-714
    • Oldenburg, J.1    Kraggerud, S.M.2    Cvancarova, M.3    Lothe, R.A.4    Fossa, S.D.5
  • 56
    • 0037384555 scopus 로고    scopus 로고
    • Pharmacogenomic can give children safer medicines
    • Impicciatore M: Pharmacogenomic can give children safer medicines. Arch Dis Child 88:366, 2003
    • (2003) Arch Dis Child , vol.88 , pp. 366
    • Impicciatore, M.1
  • 57
    • 34249997024 scopus 로고    scopus 로고
    • Replicating genotype-phenotype associations
    • NCI-NHGRI Working Group on Replication in Association Studies
    • NCI-NHGRI Working Group on Replication in Association Studies, Chanock SJ, Manolio T, et al: Replicating genotype-phenotype associations. Nature 447:655-660, 2007
    • (2007) Nature , vol.447 , pp. 655-660
    • Chanock, S.J.1    Manolio, T.2
  • 59
    • 0022635031 scopus 로고
    • Effects of mild and moderate hearing impairments on language, educational, and psychosocial behavior of children
    • Davis JM, Elfenbein J, Schum R, et al: Effects of mild and moderate hearing impairments on language, educational, and psychosocial behavior of children. J Speech Hear Disord 51:53-62, 1986 (Pubitemid 16165644)
    • (1986) Journal of Speech and Hearing Disorders , vol.51 , Issue.1 , pp. 53-62
    • Davis, J.M.1    Elfenbein, J.2    Schum, R.3    Bentler, R.A.4
  • 60
    • 0031667362 scopus 로고    scopus 로고
    • Children with minimal sensorineural hearing loss: Prevalence, educational performance, and functional status
    • DOI 10.1097/00003446-199810000-00001
    • Bess FH, Dodd-Murphy J, Parker RA: Children with minimal sensorineural hearing loss: Prevalence, educational performance, and functional status. Ear Hear 19:339-354, 1998 (Pubitemid 28465218)
    • (1998) Ear and Hearing , vol.19 , Issue.5 , pp. 339-354
    • Bess, F.H.1    Dodd-Murphy, J.2    Parker, R.A.3
  • 61
    • 0036150216 scopus 로고    scopus 로고
    • Recognition of low-pass-filtered consonants in noise with normal and impaired high-frequency hearing
    • DOI 10.1121/1.1427357
    • Horwitz AR, Dubno JR, Ahlstrom JB: Recognition of low-pass-filtered consonants in noise with normal and impaired high-frequency hearing. J Acoust Soc Am 111:409-416, 2002 (Pubitemid 34093335)
    • (2002) Journal of the Acoustical Society of America , vol.111 , Issue.1 I , pp. 409-416
    • Horwitz, A.R.1    Dubno, J.R.2    Ahlstrom, J.B.3
  • 63
    • 36049033016 scopus 로고    scopus 로고
    • Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: A report from the Children's Oncology Group
    • DOI 10.1542/peds.2007-0178
    • Gurney JG, Tersak JM, Ness KK, et al: Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: A report from the Children's Oncology Group. Pediatrics 120: e1229-e1236, 2007 (Pubitemid 350085519)
    • (2007) Pediatrics , vol.120 , Issue.5
    • Gurney, J.G.1    Tersak, J.M.2    Ness, K.K.3    Landier, W.4    Matthay, K.K.5    Schmidt, M.L.6
  • 64
    • 77950481805 scopus 로고    scopus 로고
    • Critical need for international consensus on ototoxicity assessment criteria
    • Neuwelt EA, Brock P: Critical need for international consensus on ototoxicity assessment criteria. J Clin Oncol 28:1630-1632, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 1630-1632
    • Neuwelt, E.A.1    Brock, P.2
  • 65
    • 84907039716 scopus 로고
    • Developmental factors in speech recognition
    • Boothroyd A: Developmental factors in speech recognition. Int J Audiol 9:30-38, 1970
    • (1970) Int J Audiol , vol.9 , pp. 30-38
    • Boothroyd, A.1
  • 66
    • 0030814593 scopus 로고    scopus 로고
    • Normal and hearing-impaired word recognition scores for monosyllabic words in quiet and noise
    • Beattie RC, Barr T, Roup C: Normal and hearing-impaired word recognition scores for monosyllabic words in quiet and noise. Br J Audiol 31:153-164, 1997 (Pubitemid 27367648)
    • (1997) British Journal of Audiology , vol.31 , Issue.3 , pp. 153-164
    • Beattie, R.C.1    Barr, T.2    Roup, C.3
  • 67
    • 0027263938 scopus 로고
    • Speech recognition in noise by children with minimal degrees of sensorineural hearing loss
    • Crandell CC: Speech recognition in noise by children with minimal degrees of sensorineural hearing loss. Ear Hear 14:210-216, 1993
    • (1993) Ear Hear , vol.14 , pp. 210-216
    • Crandell, C.C.1
  • 68
    • 0018166160 scopus 로고
    • Room acoustics effects on monosyllabic word discrimination ability for normal and hearing-impaired children
    • Finitzo-Hieber T, Tillman TW: Room acoustics effects on monosyllabic word discrimination ability for normal and hearing-impaired children. J Speech Hear Res 21:440-458, 1978 (Pubitemid 9028171)
    • (1978) Journal of Speech and Hearing Research , vol.21 , Issue.3 , pp. 440-458
    • Finitzo-Hieber, T.1    Tillman, T.W.2
  • 71
    • 49249083377 scopus 로고    scopus 로고
    • Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma
    • Fouladi M, Chintagumpala M, Ashley D, et al: Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma. J Clin Oncol 26:3749-3755, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 3749-3755
    • Fouladi, M.1    Chintagumpala, M.2    Ashley, D.3
  • 72
    • 58949096530 scopus 로고    scopus 로고
    • Ototoxicity in children treated for osteosarcoma
    • Lewis MJ, DuBois SG, Fligor B, et al: Ototoxicity in children treated for osteosarcoma. Pediatr Blood Cancer 52:387-391, 2009
    • (2009) Pediatr Blood Cancer , vol.52 , pp. 387-391
    • Lewis, M.J.1    DuBois, S.G.2    Fligor, B.3
  • 73
    • 77950484560 scopus 로고    scopus 로고
    • Practical grading system for evaluating cisplatin ototoxicity in children
    • Chang KW, Chinosornvatana N: Practical grading system for evaluating cisplatin ototoxicity in children. J Clin Oncol 28:1788-1795, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 1788-1795
    • Chang, K.W.1    Chinosornvatana, N.2
  • 74
    • 0032947768 scopus 로고    scopus 로고
    • Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin
    • Go RS, Adjei AA: Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 17:409-422, 1999 (Pubitemid 29022420)
    • (1999) Journal of Clinical Oncology , vol.17 , Issue.1 , pp. 409-422
    • Go, R.S.1    Adjei, A.A.2
  • 75
    • 34547100275 scopus 로고    scopus 로고
    • The resurgence of platinum-based cancer chemotherapy
    • Kelland L: The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573-584, 2007
    • (2007) Nat Rev Cancer , vol.7 , pp. 573-584
    • Kelland, L.1
  • 76
    • 0034944185 scopus 로고    scopus 로고
    • L-N-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity
    • Feghali JG, Liu W, Van De Water TR: L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 111:1147-1155, 2001 (Pubitemid 32625400)
    • (2001) Laryngoscope , vol.111 , Issue.7 , pp. 1147-1155
    • Feghali, J.G.1    Liu, W.2    Van De, W.T.R.3
  • 77
    • 8544249184 scopus 로고    scopus 로고
    • Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate
    • DOI 10.1097/00129492-200411000-00009
    • Choe WT, Chinosornvatana N, Chang KW: Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Otol Neurotol 25:910-915, 2004 (Pubitemid 39491671)
    • (2004) Otology and Neurotology , vol.25 , Issue.6 , pp. 910-915
    • Choe, W.-T.1    Chinosornvatana, N.2    Chang, K.W.3
  • 79
    • 2942748653 scopus 로고    scopus 로고
    • Protective effects of alpha-tocopherol and tiopronin against cisplatin-induced ototoxicity
    • DOI 10.1080/00016480410016559
    • Fetoni AR, Sergi B, Ferraresi A, et al: Protective effects of alpha-tocopherol and tiopronin against cisplatin-induced ototoxicity. Acta Otolaryngol 124: 421-426, 2004 (Pubitemid 38797598)
    • (2004) Acta Oto-Laryngologica , vol.124 , Issue.4 , pp. 421-426
    • Fetoni, A.R.1    Sergi, B.2    Ferraresi, A.3    Paludetti, G.4    Troiani, D.5
  • 80
    • 1642338446 scopus 로고    scopus 로고
    • Vitamin E Reduces Cisplatin Ototoxicity
    • DOI 10.1097/00005537-200403000-00028
    • Kalkanis JG, Whitworth C, Rybak LP: Vitamin E reduces cisplatin ototoxicity. Laryngoscope 114: 538-542, 2004 (Pubitemid 38391921)
    • (2004) Laryngoscope , vol.114 , Issue.3 , pp. 538-542
    • Kalkanis, J.G.1    Whitworth, C.2    Rybak, L.P.3
  • 81
    • 0032938438 scopus 로고    scopus 로고
    • Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: Antioxidant defense system
    • DOI 10.1093/toxsci/47.2.195
    • Rybak LP, Husain K, Whitworth C, et al: Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: Antioxidant defense system. Toxicol Sci 47:195-202, 1999 (Pubitemid 29214827)
    • (1999) Toxicological Sciences , vol.47 , Issue.2 , pp. 195-202
    • Rybak, L.P.1    Husain, K.2    Whitworth, C.3    Somani, S.M.4
  • 82
    • 0032694345 scopus 로고    scopus 로고
    • Application of antioxidants and other agents to prevent cisplatin ototoxicity
    • DOI 10.1097/00005537-199911000-00003
    • Rybak LP, Whitworth C, Somani S: Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope 109:1740-1744, 1999 (Pubitemid 29533912)
    • (1999) Laryngoscope , vol.109 , Issue.11 , pp. 1740-1744
    • Rybak, L.P.1    Whitworth, C.2    Somani, S.3
  • 83
    • 58149395091 scopus 로고    scopus 로고
    • Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat
    • Mukherjea D, Jajoo S, Whitworth C, et al: Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat. J Neurosci 28:13056-13065, 2008
    • (2008) J Neurosci , vol.28 , pp. 13056-13065
    • Mukherjea, D.1    Jajoo, S.2    Whitworth, C.3
  • 85
    • 0037966412 scopus 로고    scopus 로고
    • Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig
    • DOI 10.1016/S0028-3908(03)00194-1
    • Wang J, Lloyd Faulconbridge RV, Fetoni A, et al: Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig. Neuropharmacology 45:380-393, 2003 (Pubitemid 36836134)
    • (2003) Neuropharmacology , vol.45 , Issue.3 , pp. 380-393
    • Wang, J.1    Lloyd, F.R.V.2    Fetoni, A.3    Guitton, M.J.4    Pujol, R.5    Puel, J.L.6
  • 86
    • 0029125122 scopus 로고
    • The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity
    • Church MW, Kaltenbach JA, Blakley BW, et al: The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity. Hear Res 86:195-203, 1995
    • (1995) Hear Res , vol.86 , pp. 195-203
    • Church, M.W.1    Kaltenbach, J.A.2    Blakley, B.W.3
  • 88
    • 0036091647 scopus 로고    scopus 로고
    • Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action
    • DOI 10.1038/labinvest.3780453
    • Li G, Sha SH, Zotova E, et al: Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab Invest 82:585-596, 2002 (Pubitemid 34522371)
    • (2002) Laboratory Investigation , vol.82 , Issue.5 , pp. 585-596
    • Li, G.1    Sha, S.-H.2    Zotova, E.3    Arezzo, J.4    Van De, W.T.R.5    Schacht, J.6
  • 89
    • 13844266756 scopus 로고    scopus 로고
    • Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen
    • DOI 10.1016/j.heares.2004.08.002
    • Lynch ED, Gu R, Pierce C, et al: Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 201:81-89, 2005 (Pubitemid 40255547)
    • (2005) Hearing Research , vol.201 , Issue.1-2 , pp. 81-89
    • Lynch, E.D.1    Gu, R.2    Pierce, C.3    Kil, J.4
  • 90
    • 0030561543 scopus 로고    scopus 로고
    • D-Methionine provides excellent protection from cisplatin ototoxicity in the rat
    • DOI 10.1016/S0378-5955(96)00152-9, PII S0378595596001529
    • Campbell KC, Rybak LP, Meech RP, et al: D-methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 102:90-98, 1996 (Pubitemid 26388984)
    • (1996) Hearing Research , vol.102 , Issue.1-2 , pp. 90-98
    • Campbell, K.C.M.1    Rybak, L.P.2    Meech, R.P.3    Hughes, L.4
  • 91
    • 0842284222 scopus 로고    scopus 로고
    • Assessment of the Protective Effects of Amifostine against Cisplatin-Induced Toxicity
    • Hussain AE, Blakley BW, Nicolas M, et al: Assessment of the protective effects of amifostine against cisplatin-induced toxicity. J Otolaryngol 32: 294-297, 2003 (Pubitemid 38175959)
    • (2003) Journal of Otolaryngology , vol.32 , Issue.5 , pp. 294-297
    • Hussain, A.E.1    Blakley, B.W.2    Nicolas, M.3    Balderston, J.4
  • 92
    • 59849098027 scopus 로고    scopus 로고
    • Cisplatin-induced ototoxicity: Effect of intratympanic dexamethasone injections
    • Hill GW, Morest DK, Parham K: Cisplatin-induced ototoxicity: Effect of intratympanic dexamethasone injections. Otol Neurotol 29:1005-1011, 2008
    • (2008) Otol Neurotol , vol.29 , pp. 1005-1011
    • Hill, G.W.1    Morest, D.K.2    Parham, K.3
  • 93
    • 75749128927 scopus 로고    scopus 로고
    • Ototoxic drugs: Difference in sensitivity between mice and guinea pigs
    • Poirrier AL, Van den Ackerveken P, Kim TS, et al: Ototoxic drugs: Difference in sensitivity between mice and guinea pigs. Toxicol Lett 193:41-49, 2010
    • (2010) Toxicol Lett , vol.193 , pp. 41-49
    • Poirrier, A.L.1    Van Den Ackerveken, P.2    Kim, T.S.3
  • 95
    • 85027922952 scopus 로고    scopus 로고
    • The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats
    • Paksoy M, Ayduran E, Sanli A, et al: The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats. Med Oncol 28:615-621, 2011
    • (2011) Med Oncol , vol.28 , pp. 615-621
    • Paksoy, M.1    Ayduran, E.2    Sanli, A.3
  • 96
    • 2342441227 scopus 로고    scopus 로고
    • Round window application of D-methionine, sodium thiosulfate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity
    • DOI 10.1097/00129492-200401000-00007
    • Wimmer C, Mees K, Stumpf P, et al: Round window application of D-methionine, sodium thiosulfate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity. Otol Neurotol 25:33-40, 2004 (Pubitemid 39077568)
    • (2004) Otology and Neurotology , vol.25 , Issue.1 , pp. 33-40
    • Wimmer, C.1    Mees, K.2    Stumpf, P.3    Welsch, U.4    Reichel, O.5    Suckfull, M.6
  • 97
    • 77954754161 scopus 로고    scopus 로고
    • Role of the copper transporter, CTR1, in platinum-induced ototoxicity
    • More SS, Akil O, Ianculescu AG, et al: Role of the copper transporter, CTR1, in platinum-induced ototoxicity. J Neurosci 30:9500-9509, 2010
    • (2010) J Neurosci , vol.30 , pp. 9500-9509
    • More, S.S.1    Akil, O.2    Ianculescu, A.G.3
  • 98
    • 0036598487 scopus 로고    scopus 로고
    • Round window application of D-methionine provides complete cisplatin otoprotection
    • DOI 10.1067/mhn.2002.125299
    • Korver KD, Rybak LP, Whitworth C, et al: Round window application of D-methionine provides complete cisplatin otoprotection. Otolaryngol Head Neck Surg 126:683-689, 2002 (Pubitemid 41115249)
    • (2002) Otolaryngology - Head and Neck Surgery , vol.126 , Issue.6 , pp. 683-689
    • Korver, K.D.1    Rybak, L.P.2    Whitworth, C.3    Campbell, K.M.4
  • 102
    • 73149120511 scopus 로고    scopus 로고
    • Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: A report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group
    • Katzenstein HM, Chang KW, Krailo M, et al: Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: A report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group. Cancer 115:5828-5835, 2009
    • (2009) Cancer , vol.115 , pp. 5828-5835
    • Katzenstein, H.M.1    Chang, K.W.2    Krailo, M.3
  • 104
    • 34548481762 scopus 로고    scopus 로고
    • Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer
    • DOI 10.1200/JCO.2006.08.9540
    • Zuur CL, Simis YJ, Lansdaal PE, et al: Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer. J Clin Oncol 25:3759-3765, 2007 (Pubitemid 47372618)
    • (2007) Journal of Clinical Oncology , vol.25 , Issue.24 , pp. 3759-3765
    • Zuur, C.L.1    Simis, Y.J.2    Lansdaal, P.E.3    Hart, A.A.4    Schornagel, J.H.5    Dreschler, W.A.6    Rasch, C.R.7    Balm, A.J.8
  • 105
    • 58149335531 scopus 로고    scopus 로고
    • American Society of Clinical Oncology 2008 clinical practice guideline update: Use of chemotherapy and radiation therapy protectants
    • Hensley ML, Hagerty KL, Kewalramani T, et al: American Society of Clinical Oncology 2008 clinical practice guideline update: Use of chemotherapy and radiation therapy protectants. J Clin Oncol 27: 127-145, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 127-145
    • Hensley, M.L.1    Hagerty, K.L.2    Kewalramani, T.3
  • 108
    • 18844383751 scopus 로고    scopus 로고
    • Combined oral delivery of ebselen and allopurinol reduces multiple cisplatin toxicities in rat breast and ovarian cancer models while enhancing anti-tumor activity
    • DOI 10.1097/00001813-200506000-00013
    • Lynch ED, Gu R, Pierce C, et al: Combined oral delivery of ebselen and allopurinol reduces multiple cisplatin toxicities in rat breast and ovarian cancer models while enhancing anti-tumor activity. Anticancer Drugs 16:569-579, 2005 (Pubitemid 40685742)
    • (2005) Anti-Cancer Drugs , vol.16 , Issue.5 , pp. 569-579
    • Lynch, E.D.1    Gu, R.2    Pierce, C.3    Kil, J.4
  • 109
    • 46049100805 scopus 로고    scopus 로고
    • Superiority, equivalence, and non-inferiority trials
    • Lesaffre E: Superiority, equivalence, and non-inferiority trials. Bull NYU Hosp Jt Dis 66:150-154, 2008
    • (2008) Bull NYU Hosp Jt Dis , vol.66 , pp. 150-154
    • Lesaffre, E.1
  • 110
    • 7044260303 scopus 로고    scopus 로고
    • Predicting cisplatin ototoxicity in children: The influence of age and the cumulative dose
    • DOI 10.1016/j.ejca.2003.08.009, PII S0959804903007287
    • Li Y, Womer RB, Silber JH: Predicting cisplatin ototoxicity in children: The influence of age and the cumulative dose. Eur J Cancer 40:2445-2451, 2004 (Pubitemid 39424959)
    • (2004) European Journal of Cancer , vol.40 , Issue.16 , pp. 2445-2451
    • Li, Y.1    Womer, R.B.2    Silber, J.H.3
  • 111
    • 82155166492 scopus 로고    scopus 로고
    • Clinically accurate assessment and grading of ototoxicity
    • Chang KW: Clinically accurate assessment and grading of ototoxicity. Laryngoscope 121:2649-2657, 2011
    • (2011) Laryngoscope , vol.121 , pp. 2649-2657
    • Chang, K.W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.